DEST — Destiny Pharma Share News
0.000.00%
Last trade - 00:00New XF-73 research programme
Grant of share options
Brief: Destiny Pharma On Track To Achieve Strategic Targets For Xf-73 Nasal And Ntcd-M3
Result of Annual General Meeting & Strategy Update
Board Changes
Landmark NTCD-M3 data to be presented at Anaerobe
Destiny Pharma appoints Dr Yuri Martina as CMO
Posting of Annual Report and Notice of AGM
Director/PDMR Shareholding
Brief: Destiny Pharma FY Pretax Loss -6.3 Million Stg
Audited results for year ended 31 December 2021
Notice of Results
Notification of Major Holdings
To present data at ECCMID Congress
AIM - AIM Notice - 29/03/2022
Brief: Destiny Pharma Says Co Raised About £6.45 Mln From Fundraising
Result of General Meeting and Total Voting Rights
AIM - AIM Notice - 28/03/2022
Brief: Destiny Pharma Raised Total Gross Proceeds Of Approximately £0.45 Mln